(Q43902765)

27 November 2017

title

Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years (English)

1 reference

primary hyperparathyroidism

27 November 2017

1 reference

1 reference

1 reference

4

1 reference

27 November 2017

Emil Hagström

1

1 reference

27 November 2017

Ewa Lundgren

2

1 reference

27 November 2017

Hans Lithell

3

1 reference

27 November 2017

Sverker Ljunghall

5

1 reference

27 November 2017

Per Hellman

6

1 reference

27 November 2017

Jonas Rastad

7

1 reference

27 November 2017

publication date

1 February 2002

1 reference

27 November 2017

published in

Clinical Endocrinology

1 reference

27 November 2017

volume

56

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

253-260

1 reference

Hypertriglyceridemia as a cardiovascular risk factor

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Serum lipids before and after parathyroidectomy in patients with primary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Death risk factor analysis in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Increased risk of death from primary hyperparathyroidism--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Atherogenicity of triglyceride-rich lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Serum lipoprotein disturbances in primary and secondary hyperparathyroidism and effects of parathyroidectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Case-control study on symptoms and signs of "asymptomatic" primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Hormone replacement therapy and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Estrogen therapy during menopause. Practical treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Survival after surgical treatment for primary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

Outcome after surgery for primary hyperparathyroidism: ten-year prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-0664.2001.01468.X

10.1046/J.0300-0664.2001.01468.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference